These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1576046)

  • 1. A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.
    Macphee GJ; Howie CA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1992 Mar; 33(3):261-7. PubMed ID: 1576046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
    Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.
    Rupp H; Maisch B; Brilla CG
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():251-62. PubMed ID: 8827948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
    Findlay D; Lawrence JR
    Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
    Sala P; Chierichetti SM; Ferrari P
    Eur J Clin Pharmacol; 1979; 16(6):375-9. PubMed ID: 393519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moxonidine on blood pressure and sympathetic tone in conscious spontaneously hypertensive rats.
    Nurminen ML; Culman J; Haass M; Chung O; Unger T
    Eur J Pharmacol; 1998 Nov; 362(1):61-7. PubMed ID: 9865531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM; Mönig H; Mill G; Gödde E; Schulte HM
    Exp Clin Endocrinol Diabetes; 1995; 103(3):205-8. PubMed ID: 7584524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
    Szabo B; Fritz T; Wedzony K
    Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
    Dollery CT; Reid JL
    Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of moxonidine and clonidine HCl in treating patients with hypertension.
    Plänitz V
    J Clin Pharmacol; 1987 Jan; 27(1):46-51. PubMed ID: 3316304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine.
    Armah BI
    Arzneimittelforschung; 1988 Oct; 38(10):1435-42. PubMed ID: 2848533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and blood pressure effects of moxonidine and clonidine in spontaneously hypertensive rats.
    Hohage H; Hess K; Jahl C; Greven J; Schlatter E
    Clin Nephrol; 1997 Dec; 48(6):346-52. PubMed ID: 9438092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
    Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
    Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of the effects of clonidine preparations depending on methods of arterial pressure recording].
    Kunduzova OR; Murashev AN; Medvedeva NA; Medvedev OS
    Eksp Klin Farmakol; 1997; 60(6):10-2. PubMed ID: 9460588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxonidine and cognitive function: interactions with moclobemide and lorazepam.
    Wesnes K; Simpson PM; Jansson B; Grahnén A; Weimann HJ; Küppers H
    Eur J Clin Pharmacol; 1997; 52(5):351-8. PubMed ID: 9272403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effects of medetomidine and clonidine in healthy volunteers: a noninvasive echocardiographic study.
    Kallio A; Saraste M; Scheinin M; Hartiala J; Scheinin H
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):28-33. PubMed ID: 1696663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.